February 22nd, 2014

Living Life Without Limits

by Paul Flynn, North America Sales Director, Animas

Sebastien Sasseville

Animas is inspired by stories of how our products help patients with Type 1 diabetes.  Living a life without limits is our guiding mission, so when an athlete like Sebastien Sasseville attempts to run across Canada as a way to inspire others to face challenges, it fills us with pride and determination to share his story.

Sebastien is a six-time Ironman triathlete and a conqueror of Mt. Everest who was diagnosed with Type 1 diabetes in 2002 . Thanks in part to Animas, his latest project, Outrun Diabetes, is about overcoming obstacles, whether it is diabetes or any other hurdle people are dealing with in their lives. He hopes his journey will motivate others to purse and accomplish their own personal goals.

As Sebastien traverses across Canada, he will be stopping in cities including Halifax, Moncton, Quebec City, Montreal, Ottawa, Windsor, Toronto, Winnipeg, Regina, Saskatoon, Edmonton and Calgary before he reaches the finish line in Vancouver.  Along the way, he will host events and education seminars in local communities to help raise awareness for diabetes.

To learn more about Sebastien or to follow his journey, please check back at Outrun Diabetes throughout the coming months.



Paul FlynnPaul Flynn is the North American Sales Director for Animas® Corporation. In this role, he is responsible for leading the insulin delivery sales force throughout Canada and the United States.

Paul brings with him more than 22 years of experience at Johnson & Johnson. Prior to his current role, Paul was the Director for Animas Canada and International Business Development and was responsible for business operations and strategic direction for the company. In total, he has worked within the diabetes space for over 12 years.

Paul is a father, husband and an avid cyclist.

Leave a Reply

All comments will be reviewed before posting. Since this blog is about Johnson & Johnson, comments that don’t directly relate to the Company or to topics covered on this blog won’t be posted. Please see our comments policy for details.